Press release
Global Gene Therapy For Retinal Diseases Market | Applied Genetic Technologies Corporation, Adverum Biotechnologies, ProQR Therapeutics, MeiraGTx Limited., Oxford BioMedica, Horama S.A., Gensight Biologics, Regenxbio Inc., Spark Therapeutics, Inc., Genzym
Request for Sample Pages: https://www.insightaceanalytic.com/report/global-gene-therapy-for-retinal-diseases-market-/1157
According to the latest research study by InsightAce Analytic, the global gene therapy for retinal diseases market is expected to grow with a CAGR of 32.7% during the forecast period of 2020-2030. By region, North America and Europe dominated the global market.
Gene therapy is a technique of introducing genes into host cells to treat a disease. The tremendous potential of gene therapy to treat various ocular diseases is boosting the global demand for gene therapies for retinal diseases. With limited treatment options for inherited retinal diseases, gene therapy has been established as a safe, feasible, and effective treatment.
The growth of the gene therapy for retinal diseases market can be attributed to several factors, such as the growing adoption of gene therapy for retinal disorders, high prevalence of chronic and retinal diseases, growing geriatric population, increasing number of clinical trials for retinal gene therapies, and their positive results, growing demand for effective treatments, and the increasing government funding for healthcare research. The rising prevalence of diabetes across all countries is propelling the number of retinal diseases such as diabetic retinopathy, diabetic macular edema, etc. According to the National Eye Institute (NEI), by 2030 and 2050, approximately 10 & 14 million people respectively are expected to suffer from diabetic retinopathy in America. This emergence of retinal diseases is increasing R&D activities, leading to the innovation and adoption of gene therapy for retinal disorders, likely to fuel the market growth over the estimated timeframe.
However, expensive gene therapies are expected to limit the market growth during the forecast period.
Regionally, North America is projected to hold the highest market share during the forecast years 2020-2030, followed by Europe, owing to the fast adoption of advanced therapy techniques, the significant presence of research institutes and biopharmaceutical companies, and the well-established healthcare infrastructure.
Request for ToC/Proposal: https://www.insightaceanalytic.com/report/global-gene-therapy-for-retinal-diseases-market-/1157
The key players operating in the gene therapy for retinal diseases market include Applied Genetic Technologies Corporation (US), Adverum Biotechnologies (US), ProQR Therapeutics (Netherlands), MeiraGTx Limited. (UK), Oxford BioMedica (UK), Horama S.A. (France), Gensight Biologics (France), Regenxbio Inc. (US), Spark Therapeutics, Inc. (US), Genzyme (Sanofi) (US), Novartis Pharmaceuticals (Switzerland), Nightstar Therapeutics (Biogen) (US), Hemera Biosciences (US) among others.
Key developments in the market:
• In September 2021, Applied Genetic Technologies Corporation (AGTC) (US), a biotechnology company developing gene therapies for treating rare diseases, joined the My Retina Tracker Program as a new scientific collaborator. This initiative can enhance the development of its gene therapies for inherited retinal diseases (IRDs). The My Retina Tracker Program offers individuals with IRDs easy access to high-quality genetic diagnostics and genetic counseling.
• In October 2020, Novartis (Switzerland) acquired Vedere Bio, a company developing next-generation ocular gene therapies. This acquisition builds on the company’s commitment to cell and gene therapy. It will also enable Novartis to advance further its efforts to bring transformative therapies to a wide range of patients with blinding diseases.
• In June 2019, Oxford BioMedica (UK) and Santen Pharmaceutical, the market leader for prescription ophthalmic pharmaceuticals in Japan, agreed to jointly conduct R&D activities for gene therapy products. Under an R&D collaboration and an option and license agreement, the companies can use OXB’s lentiviral vectors to generate pre-clinical, proof-of-concept evidence to innovate treatments for inherited retinal disease.
Market Segments
Global Gene Therapy For Retinal Diseases Market, by Indication, 2020-2030 (Valu US$ Mn)
• Choroideremia (CHM)
• Leber congenital amaurosis
• Leber’s hereditary optic neuropathy
• X-linked retinitis pigmentosa
• Other Indication
Global Gene Therapy For Retinal Diseases Market, by Region, 2020-2030 (Value US$ Mn)
• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa
North America Gene Therapy For Retinal Diseases Market, by Country, 2020-2030 (Value US$ Mn)
• U.S.
• Canada
Europe Gene Therapy For Retinal Diseases Market, by Country, 2020-2030 (Value US$ Mn)
• Germany
• France
• Italy
• Spain
• Russia
• Rest of Europe
Asia Pacific Gene Therapy For Retinal Diseases Market, by Country, 2020-2030 (Value US$ Mn)
• India
• China
• Japan
• South Korea
• Australia & New Zealand
Latin America Gene Therapy For Retinal Diseases Market, by Country, 2020-2030 (Value US$ Mn)
• Brazil
• Mexico
• Rest of Latin America
Middle East & Africa Gene Therapy For Retinal Diseases Market, by Country, 2020-2030 (Value US$ Mn)
• GCC Countries
• South Africa
• Rest of Middle East & Africa
Why should buy this report:
To receive a comprehensive analysis of the prospects for the global gene therapy for retinal diseases market
To receive an industry overview and future trends of the gene therapy for retinal diseases market
To analyze the gene therapy for retinal diseases market drivers and challenges
To get information on the gene therapy for retinal diseases market size (Value US$ Mn) forecast to 2030
Major investments, mergers & acquisitions in the gene therapy for retinal diseases market industry
For More Information @ https://www.insightaceanalytic.com/report/global-gene-therapy-for-retinal-diseases-market-/1157
InsightAce Analytic Pvt. Ltd.
Tel.: +1 551 226 6109
Email: info@insightaceanalytic.com
Site Visit: www.insightaceanalytic.com
Follow Us on LinkedIn @ bit.ly/2tBXsgS
Follow Us On Facebook @ bit.ly/2H9jnDZ
InsightAce Analytic is a market research and consulting firm that enables clients to make strategic decisions. Our qualitative and quantitative market intelligence solutions inform the need for market and competitive intelligence to expand businesses. We help clients gain competitive advantage by identifying untapped markets, exploring new and competing technologies, segmenting potential markets and repositioning products. Our expertise is in providing syndicated and custom market intelligence reports with an in-depth analysis with key market insights in a timely and cost-effective manner.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Global Gene Therapy For Retinal Diseases Market | Applied Genetic Technologies Corporation, Adverum Biotechnologies, ProQR Therapeutics, MeiraGTx Limited., Oxford BioMedica, Horama S.A., Gensight Biologics, Regenxbio Inc., Spark Therapeutics, Inc., Genzym here
News-ID: 2448969 • Views: …
More Releases from InsightAce Analytic Pvt. Ltd.
Organic Feminine Care Market to Benefit from Increasing Government Initiatives a …
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Organic Feminine Care Market Size, Share & Trends Analysis Report By Product Type (Sanitary Pads, Tampons, Menstrual Cups, Liners and Shields, Others), by Nature (Disposable, Reusable), by Age Group (Upto 18 Years, 19-30 Years, 31-40 Years, 41 Years and Above), by Distribution Channel (Supermarkets and hypermarkets, Pharmacy, Online Stores, Others)- Market Outlook And Industry Analysis…
Intravenous Immunoglobulin Market Key Players Analysis - Biotest AG, Octapharma …
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Intravenous Immunoglobulin Market Size, Share & Trends Analysis Report By Application (Hypogammaglobulinemia, CIDP, Congenital AIDS), By Distribution Channel (hospital pharmacies, speciality pharmacies), Region, Market Outlook And Industry Analysis 2031"
The global Intravenous Immunoglobulin market is estimated to reach over USD 21.22 billion by 2031, exhibiting a CAGR of 6.60% during the forecast period.
Get Free Access…
Exascale Computing Market Key Players Analysis- Hewlett Packard Enterprise Compa …
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Exascale Computing Market - (By Component (Hardware, Software, Services), By Deployment (On-premises, Cloud-based), By Customer Type (Government & Defense, Healthcare & Biosciences, Financial Services, Research & Academia, Manufacturing & Energy, Others)), Trends, Industry Competition Analysis, Revenue and Forecast To 2031."
According to the latest research by InsightAce Analytic, the Global Exascale Computing Market is valued at…
Plasma Fractionation Market Robust Expansion is expected to 2031
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Plasma Fractionation Market- (By Product (Immune-Globulins(Intravenous Immune-Globulins, Subcutaneous Immune-Globulins, Other Immune-Globulins), Coagulation Factor Concentrates (Factor VIII, Factor IX, Von Willebrand Factor, Prothrombin Complex Concentrate, Fibrinogen Concentrates, Factor XIII, Others), Albumin, Protease Inhibitors, Other Plasma Products), By Application (Neurology, Immunology, Hematology, Critical Care, Pulmonology, Hemato-Oncology, Rheumatology, Others), By End-User (Hospitals & Clinics, Clinical Research Laboratories, Academic Institutes)),…
More Releases for Gene
DNA and Gene Cloning Services Market Expands with Growing Focus on Complex Gene …
InsightAce Analytic Pvt. Ltd. has announced the publication of a market research report titled "Global DNA and Gene Cloning Services Market by Type of Service Offered (Custom Cloning, Sub-cloning, Gene Synthesis, and Others), Type of Gene (Complex Gene, Standard Gene, and Others), End-User Industry (Pharmaceutical, Academic and R&D, and Biotechnology Companies, and Others)- Market Outlook and Industry Analysis 2034"
The DNA and Gene Cloning Services Market Size is valued…
Evolving Market Trends In The CRISPR Gene Editing Industry: Innovative Gene Ther …
The CRISPR Gene Editing Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].
What Is the Expected CRISPR Gene Editing Market Size During the Forecast Period?
The CRISPR gene editing market has grown exponentially in recent years. It will grow from $2.26 billion in 2024 to $2.88…
Cell and Gene Therapy Market Global Analysis By Type (Cell Therapy, Gene Therapy …
Gene and cell therapy uses genes and cells for the treatment of genetic diseases. Genetic diseases are caused by mutations, or errors in genes which can be passed down from one generation to another. Gene therapy aims to treat diseases by using genetic material, or DNA, to manipulate a patient's cells by replacing, changing or introducing genome into cells- either internally or externally. Cell therapy aims to treat diseases by…
Competitive and Opportunities Analysis of Gene Therapy Market of Gene Therapy Ma …
Global Gene Therapy Market accounted for US$ 2.05 billion in 2020 and is estimated to be US$ 12.29 billion by 2030 and is anticipated to register a CAGR of 19.8%. Gene therapy means fixing a working gene to an individual who features a damaged gene. The European Commission has approved this method for one particular treatment. The treatment by the merchandise Glybera uses an epidemic to infect muscle cells with…
Genetic Testing Market Size by Growth Opportunities, Top Key Players: GeneDx, In …
Genetic Testing Market Report provides an in-depth analysis of the overall market, The ripple effect of Coronavirus-Covid19 on the market needs to become part of strategy discussions to emerge strong. The report focuses on major key players, production details, their application, countries and also analyzes the global and key regions market potential and advantage, opportunity, and challenge, restraints, and risks.
The Top players Covered in report are GeneDx, Invitae, Pathway Genomics,…
Gene Synthesis Market by Top Manufacturers - Gene script, Gene Art (Thermofische …
The "Gene Synthesis Market" report Added by "Big Market Research", enumerates information about the industry in terms of market share, market size, revenue forecasts, and regional outlook. The report further illustrates competitive insights of key players in the business vertical followed by an overview of their diverse portfolios and growth strategies.
In the Gene Synthesis Market 2018 research report professionals describe the different facets of the industry with a specific goal…
